Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 689.90
+8.10 (1.19%)
Jun 12, 2026, 1:44 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 206.47 million as of June 12, 2026. Its market cap has decreased by -25.44% in one year.
Market Cap
206.47M
Enterprise Value
180.71M
Revenue
679.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
689.90
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 206.47M, a decrease of -82.87%. That is a compound annual growth rate of -32.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 206.47M | 13.31% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 117.68B |
| Danel (Adir Yeoshua) | 2.89B |
| Amal Holdings A.D. | 2.49B |
| BrainsWay | 1.73B |
| Novolog (Pharm-Up 1966) | 415.34M |
| Bonus BioGroup | 381.98M |
| Geffen Residence & Renewal | 320.88M |
| Golden House | 160.44M |